The Adjuvanticity of an O. volvulus-Derived rOv-ASP-1 Protein in Mice Using Sequential Vaccinations and in Non-Human Primates
出版年份 2012 全文链接
标题
The Adjuvanticity of an O. volvulus-Derived rOv-ASP-1 Protein in Mice Using Sequential Vaccinations and in Non-Human Primates
作者
关键词
-
出版物
PLoS One
Volume 7, Issue 5, Pages e37019
出版商
Public Library of Science (PLoS)
发表日期
2012-05-18
DOI
10.1371/journal.pone.0037019
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Intranasal Vaccination of Recombinant Adeno-Associated Virus Encoding Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Spike Protein Induces Strong Mucosal Immune Responses and Provides Long-Term Protection against SARS-CoV Infection
- (2014) L. Du et al. JOURNAL OF IMMUNOLOGY
- Cancer Vaccines. Any Future?
- (2011) Lukasz A. Myc et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Trends in vaccine adjuvants
- (2011) Virgil EJC Schijns et al. Expert Review of Vaccines
- Recent Developments in Cancer Vaccines
- (2011) K. Palucka et al. JOURNAL OF IMMUNOLOGY
- Immunological mechanisms of vaccination
- (2011) Bali Pulendran et al. NATURE IMMUNOLOGY
- Alum's adjuvant action: grease is the word
- (2011) M Lamine Mbow et al. NATURE MEDICINE
- Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity
- (2011) Tracy L Flach et al. NATURE MEDICINE
- A novel, helminth-derived immunostimulant enhances human recall responses to hepatitis C virus and tetanus toxoid and is dependent on CD56+ cells for its action
- (2010) A. J. MacDonald et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant
- (2010) Guangyu Zhao et al. VACCINE
- A 219-mer CHO-Expressing Receptor-Binding Domain of SARS-CoV S Protein Induces Potent Immune Responses and Protective Immunity
- (2010) Lanying Du et al. VIRAL IMMUNOLOGY
- Enhancing Oral Vaccine Potency by Targeting Intestinal M Cells
- (2010) Ali Azizi et al. PLoS Pathogens
- Recombinant Ov-ASP-1, a Th1-Biased Protein Adjuvant Derived from the Helminth Onchocerca volvulus, Can Directly Bind and Activate Antigen-Presenting Cells
- (2009) Y. He et al. JOURNAL OF IMMUNOLOGY
- Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity
- (2009) Lanying Du et al. VIROLOGY
- Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines
- (2008) Wenjun Xiao et al. VACCINE
- Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection
- (2008) Lanying Du et al. VACCINE
- Rationally-designed vaccine adjuvants: separating efficacy from toxicity
- (2007) Travis et al. Frontiers in Bioscience-Landmark
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started